{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T23:56:26Z","timestamp":1769644586334,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100031470","name":"Sociedad Espa\u00f1ola de Medicina Interna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031470","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola (English Edition)"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.rceng.2025.502352","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T15:58:27Z","timestamp":1756828707000},"page":"502352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["From obesity to comorbidities: a comprehensive care approach for improved health by the Spanish Society of Internal Medicine"],"prefix":"10.1016","volume":"225","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7754-6090","authenticated-orcid":false,"given":"J.","family":"Carretero G\u00f3mez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Fern\u00e1ndez Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Michan Do\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"Miramontes Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.J.","family":"Gonz\u00e1lez Soler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.I.","family":"P\u00e9rez Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.J.","family":"Carrasco S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"G\u00f3mez Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Ar\u00e9valo Lorido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"P\u00e9rez Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rceng.2025.502352_bib0005","unstructured":"World Health Organization. Obesity and overweight. [Accessed 15 April 2025]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"key":"10.1016\/j.rceng.2025.502352_bib0010","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.recesp.2020.12.013","article-title":"Prevalence of obesity and associated cardiovascular risk factors in the Spanish population: the ENPE study","volume":"75","author":"P\u00e9rez-Rodrigo","year":"2022","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.rceng.2025.502352_bib0015","series-title":"Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: the Evidence Report","year":"1998"},{"key":"10.1016\/j.rceng.2025.502352_bib0020","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1001\/jama.293.15.1861","article-title":"Excess deaths associated with underweight, overweight, and obesity","volume":"293","author":"Flegal","year":"2005","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.rceng.2025.502352_bib0025","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMra1514009","article-title":"Mechanisms, pathophysiology, and management of obesity","volume":"376","author":"Heymsfield","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rceng.2025.502352_bib0030","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.rceng.2025.502352_bib0035","doi-asserted-by":"crossref","first-page":"e1103","DOI":"10.1210\/clinem\/dgae341","article-title":"Defining overweight and obesity by percent body fat instead of body mass index","volume":"110","author":"Potter","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rceng.2025.502352_bib0040","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.numecd.2024.06.016","article-title":"Bioelectrical impedance-derived phase angle (PhA) in people living with obesity: role in sarcopenia and comorbidities","volume":"34","author":"Carretero G\u00f3mez","year":"2024","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"9669","key":"10.1016\/j.rceng.2025.502352_bib0045","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(09)60318-4","article-title":"Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies","volume":"373","author":"Whitlock","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.rceng.2025.502352_bib0050","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0140-6736(16)30175-1","article-title":"Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents","volume":"388","author":"Di Angelantonio","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.rceng.2025.502352_bib0055","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S2213-8587(25)00159-7","article-title":"Prevalence of clinical obesity versus BMI-defined obesity among US adults: a cohort study","volume":"13","author":"Yaoa","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.rceng.2025.502352_bib0060","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ijo.2009.2","article-title":"A proposed clinical staging system for obesity","volume":"33","author":"Sharma","year":"2009","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.rceng.2025.502352_bib0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.rce.2016.11.003","article-title":"Prevalence of obesity according to Edmonton staging in the Internal Medicine consultations. Results of the OBEMI study","volume":"217","author":"Carretero G\u00f3mez","year":"2017","journal-title":"Rev Clin Esp (Barc)"},{"key":"10.1016\/j.rceng.2025.502352_bib0070","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.3390\/jcm11164644","article-title":"High-risk obesity phenotypes: target for multimorbidity prevention at the ROFEMI study","volume":"11","author":"Carretero-G\u00f3mez","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.rceng.2025.502352_bib0075","first-page":"1","article-title":"The Spanish GIRO guideline: a paradigm shift in the management of obesity in adults","author":"Lecube","year":"2025","journal-title":"Obes Facts"},{"key":"10.1016\/j.rceng.2025.502352_bib0080","doi-asserted-by":"crossref","first-page":"E875","DOI":"10.1503\/cmaj.191707","article-title":"Obesity in adults: a clinical practice guideline","volume":"192","author":"Wharton","year":"2020","journal-title":"CMAJ"},{"key":"10.1016\/j.rceng.2025.502352_bib0085","unstructured":"[Accessed 23 July 2025]. Available from: https:\/\/protocolos.fesemi.org\/#\/protocolo\/obesidad-y-comorbilidades."},{"key":"10.1016\/j.rceng.2025.502352_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110867","article-title":"The weight reduction mediated by anti-obesity medication and the cardiovascular outcome","volume":"27","author":"Guo","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.rceng.2025.502352_bib0095","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rceng.2025.502352_bib0100","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.rceng.2025.502352_bib0105","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.jacc.2024.07.016","article-title":"Heart failure and obesity: unraveling molecular mechanisms of excess adipose tissue","volume":"84","author":"Dronkers","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rceng.2025.502352_bib0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2025.05.008","article-title":"2025 ACC scientific statement on the management of obesity in adults with heart failure: a report of the American College of Cardiology","author":"Kittleson","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rceng.2025.502352_bib0115","first-page":"1","article-title":"American Association of Clinical Endocrinologists and American College of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity","volume":"22 Suppl 3","author":"Garvey","year":"2016","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"key":"10.1016\/j.rceng.2025.502352_bib0120","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0140-6736(24)00469-0","article-title":"Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials","volume":"403","author":"Butler","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.rceng.2025.502352_bib0125","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rceng.2025.502352_bib0130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jacep.2015.04.004","article-title":"Obesity and the risk of incident, postoperative, and postablation atrial fibrillation: a metaanalysis of 626,603 individuals in 51 studies","volume":"1","author":"Wong","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.rceng.2025.502352_bib0135","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.032277","article-title":"Impact of obesity on atrial fibrillation pathogenesis and treatment options","volume":"13","author":"Sha","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.rceng.2025.502352_bib0140","doi-asserted-by":"crossref","DOI":"10.1177\/10760296231153638","article-title":"Pharmacokinetics and dosing regimens of direct oral anticoagulants in morbidly obese patients: an updated literature review","volume":"29","author":"Zhao","year":"2023","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.rceng.2025.502352_bib0145","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1538-7836.2007.02565.x","article-title":"Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials","volume":"5","author":"Davidson","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rceng.2025.502352_bib0150","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1046\/j.1523-1755.2001.0590041498.x","article-title":"Obesity-related glomerulopathy: an emerging epidemic","volume":"59","author":"Kambham","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.rceng.2025.502352_bib0155","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11684-017-0570-3","article-title":"Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment","volume":"11","author":"Xu","year":"2017","journal-title":"Front Med"},{"key":"10.1016\/j.rceng.2025.502352_bib0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117589","article-title":"Empagliflozin attenuating renal interstitial fibrosis in diabetic kidney disease by inhibiting lymphangiogenesis and lymphatic endothelial-to-mesenchymal transition via the VEGF-C\/VEGFR3 pathway","volume":"180","author":"Huang","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.rceng.2025.502352_bib0165","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rceng.2025.502352_bib0170","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S2213-8587(22)00243-1","article-title":"Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial","volume":"10","author":"Heerspink","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.rceng.2025.502352_bib0175","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.rceng.2025.502352_bib0180","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rceng.2025.502352_bib0185","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rceng.2025.502352_bib0190","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa2401755","article-title":"A phase 2 randomized trial of survodutide in MASH and fibrosis","volume":"391","author":"Sanyal","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rceng.2025.502352_bib0195","doi-asserted-by":"crossref","first-page":"105639","DOI":"10.1016\/j.jbspin.2023.105639","article-title":"Osteoarthritis in patients with obesity: the bariatric surgery impacts on its evolution","volume":"91","author":"Eymard","year":"2024","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.rceng.2025.502352_bib0200","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s42836-024-00252-4","article-title":"Preoperative weight loss interventions before total hip and knee arthroplasty: a systematic review of randomized controlled trials","volume":"6","author":"Lau","year":"2024","journal-title":"Arthroplasty"},{"key":"10.1016\/j.rceng.2025.502352_bib0205","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJMoa2403664","article-title":"Once-weekly semaglutide in persons with obesity and knee osteoarthritis","volume":"391","author":"Bliddal","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rceng.2025.502352_bib0210","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1056\/NEJMcp1816152","article-title":"Obstructive sleep apnea in adults","volume":"380","author":"Veasey","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rceng.2025.502352_bib0215","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1164\/rccm.201807-1326ST","article-title":"The role of weight management in the treatment of adult obstructive sleep apnea. An Official American Thoracic Society Clinical Practice Guideline","volume":"198","author":"Hudgel","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rceng.2025.502352_bib0220","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ijo.2016.52","article-title":"Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial","volume":"40","author":"Blackman","year":"2016","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.rceng.2025.502352_bib0225","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N Engl J Med"}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S225488742500092X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S225488742500092X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:46:00Z","timestamp":1769604360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S225488742500092X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S225488742500092X"],"URL":"https:\/\/doi.org\/10.1016\/j.rceng.2025.502352","relation":{},"ISSN":["2254-8874"],"issn-type":[{"value":"2254-8874","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From obesity to comorbidities: a comprehensive care approach for improved health by the Spanish Society of Internal Medicine","name":"articletitle","label":"Article Title"},{"value":"Revista Cl\u00ednica Espa\u00f1ola (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rceng.2025.502352","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rce.2025.502352","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Medicina Interna (SEMI). All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"502352"}}